Calpain acts as downstream mediators in Ang II-induced cardiovascular remodeling, while calpastatin, a calpain-specific inhibitor, was able to prevent Ang II-dependent cardiac hypertrophy and perivascular inflammation (158). Here, AGT is linked to cardiac hypertrophy.